May 4, 2020 / 12:11 PM / 24 days ago

BRIEF-AC Immune On Track To Meet Five Clinical Milestones Expected In 2020

May 4 (Reuters) - AC Immune SA:

* AC IMMUNE REPORTS Q1 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* ON TRACK TO MEET FIVE CLINICAL MILESTONES EXPECTED IN 2020 WITH NO MODIFYING GUIDANCE AS A RESULT OF COVID-19

* QTRLY REVENUE TOTALED CHF 12.4 MILLION, A CHF 62.6 MILLION DECREASE

* AS OF MARCH 31, HAD A TOTAL CASH BALANCE OF CHF 277.9 MILLION

* QTRLY ADJUSTED LOSS PER SHARE CHF 0.09

* IS FULLY FINANCED THROUGH Q1 2024, EXCLUDING POTENTIAL INCOMING MILESTONES

* Q1 EARNINGS PER SHARE VIEW CHF -0.14, REVENUE VIEW CHF 12.9 MILLION — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below